News from exosome diagnostics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 04, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of Thomas McLain as Chief Executive Officer

 Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced the appointment of Thomas...


Jun 03, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of Vincent J. O'Neill, M.D. As Chief Medical Officer

Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J. O'Neill, M.D., has...


May 28, 2014, 08:00 ET Exosome Diagnostics Announces Appointment of William J. Kelly As Chief Financial Officer

 Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that William J. Kelly has been...


Mar 11, 2014, 07:00 ET Exosome Diagnostics Raises $27 Million in Series B Financing

 Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used...


Jan 13, 2014, 02:00 ET Exosome Diagnostics and QIAGEN Expand Collaboration to Develop Non-Invasive Biofluid Diagnostic for Lung Cancer

 Exosome Diagnostics today announced an expansion of its strategic collaboration with QIAGEN to develop non-invasive molecular diagnostics for...


Sep 30, 2013, 08:00 ET Cedars-Sinai Medical Center to Use Exosome Diagnostics Exosome RNA Biofluid Kits in Neo-Natal Setting and Cancer for Development of Personalized Medicine Diagnostics

 Exosome Diagnostics today announced that it has selected Cedars-Sinai Medical Center to participate in an early technology access program for...


Sep 19, 2013, 08:00 ET Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery

 Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker...


Aug 21, 2013, 08:00 ET Mount Sinai and Exosome Diagnostics Partner to Accelerate Translation of Body Fluid Molecular Diagnostics to Overcome Limitations of Tissue Biopsy in Areas of Critical Unmet Medical Needs

 The Icahn School of Medicine at Mount Sinai and Exosome Diagnostics today announced a collaboration on the research...


Jul 23, 2013, 16:00 ET Exosome Diagnostics and QIAGEN Partner to Launch Comprehensive Line of Biofluid Nucleic Acid Kits to Address Limitations of Tissue Biopsy in Clinical Research Market

 Exosome Diagnostics and QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced a partnership to develop and commercialize...


Jul 08, 2013, 08:00 ET Exosome Diagnostics Names Joseph Slattery to the Board of Directors

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced that...


May 08, 2013, 11:00 ET Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual Meeting

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and...


Apr 29, 2013, 08:00 ET Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced that Kapil...


Apr 16, 2013, 08:00 ET Exosome Diagnostics Presents Data Demonstrating Clinical Applications of Exosome Technology in Brain Cancer, Prostate Cancer, and Alzheimer's Disease at the International Society for Extracellular Vesicles 2013 Annual Meeting

Exosome Diagnostics, a developer of biofluid-based molecular diagnostic products for use in personalized medicine, today announced data...


Apr 08, 2013, 13:00 ET Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting

 Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostics for use in personalized medicine, today announced that the...


Oct 26, 2012, 08:00 ET Exosome Diagnostics Selects Promega Corp. for cGMP Clinical Sample Concentrator Kit

Exosome Diagnostics today announced it has reached an agreement with Promega Corporation to be the exclusive supplier of its Urine Clinical Sample...


Jun 04, 2012, 08:00 ET Exosome Diagnostics Signs Agreement with Life Technologies to Use Real-Time PCR Platform for Exosome Biofluid In Vitro Oncology Diagnostics

Exosome Diagnostics today announced it has reached agreement with Life Technologies to use the Applied Biosystems® (ABI) 7500 Fast Dx...


May 23, 2012, 10:30 ET Exosome Diagnostics Presents Data at American Urology Association Demonstrating Potential Utility of Urine Exosomes to Non-invasively Detect and Manage Prostate Cancer

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics,...


Mar 28, 2012, 08:30 ET Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized and non-invasive cancer diagnostics,...


Feb 06, 2012, 08:00 ET Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer

 Accelerate Brain Cancer Cure (ABC2) and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate...


Feb 01, 2012, 08:00 ET EUR 1.0 Million Grant Awarded to Exosome Diagnostics and Ludwig Maximilian University from German Federal Ministry for Education and Research to Develop Biofluid-Derived Exosome Diagnostics

 Exosome Diagnostics GmbH, a subsidiary of Exosome Diagnostics, Inc., and the Department of Dermatology at the Ludwig Maximilian...


Oct 13, 2011, 08:00 ET The Prostate Cancer Foundation and Exosome Diagnostics Collaborate to Accelerate Clinical Validation of Exosome Biofluid Molecular Diagnostics in Prostate Cancer

The Prostate Cancer Foundation (PCF) and Exosome Diagnostics today are announcing a multi-year collaboration to accelerate clinical validation of...


Oct 04, 2011, 07:00 ET Exosome Diagnostics Announces Additions to Management and Scientific Advisory Board as Company Expands Clinical Validation Studies in Oncology

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic tests for use in personalized medicine, today announced the...


Jul 23, 2009, 09:14 ET Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer

Zdechlik was Founding member of the U.S. Clinical Molecular Diagnostic Group Exosome Diagnostics, Inc., the developer of non-invasive...


Jun 22, 2009, 10:00 ET Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations

Exosome Diagnostics, Inc. ("ExosomeDX") and DxS Ltd. ("DxS") today announced that they will collaborate on the development of blood-based companion...


Nov 17, 2008, 13:48 ET Blood Exosomes Shown to Contain Tumor-Specific Genetic Information for Brain Cancer

Exosome Diagnostics Developing Blood Test to Help Monitor Status and Eligibility of Brain Tumors to Drug Treatments Tiny vesicles called...